October 23, 2016 6:09 PM ET


Company Overview of Ironwood Pharmaceuticals, Inc.

Executive Profile

Lawrence S. Olanoff M.D., Ph.D.

Director, Member of Pharmaceuticals Advisory Committee and Member of Governance & Nominating Committee, Ironwood Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 6 different industries.

See Board Relationships


Dr. Lawrence S. Olanoff, also known as Larry, M.D., Ph.D., serves as an Adjunct Assistant Professor and Special Advisor to the President for Corporate Relations at the Medical University of South Carolina (MUSC). Dr. Olanoff served as Senior Scientific Advisor of Forest Laboratories Inc. (alternate name Forest Laboratories, LLC) since December 31, 2010. He has an extensive drug development experience. He served as Chief Operating Officer and President of Forest Laboratories ...

Corporate Headquarters

301 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-621-7722
Fax: 617-494-0480

Board Members Memberships

Senior Scientific Advisor, Director and Member of Disclosure, Legal Compliance & Risk Management Committee
Director, Member of Pharmaceuticals Advisory Committee and Member of Governance & Nominating Committee


Case Western Reserve University
Case Western Reserve University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$12,500
Total Calculated Compensation$287,110

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Michael W. Aguiar Chief Executive Officer, President, Director and Member of Stock Option Committee
Innoviva, Inc.
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science Committee
Progenics Pharmaceuticals, Inc.
Peter S. Greenleaf Chairman and Chief Executive Officer
Sucampo Pharmaceuticals, Inc.
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ironwood Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.